8-KAccepted Nov 12, 5:21 PM ET
Akari Therapeutics Plc: reports Q3 2026 financial results
Accepted (ET)
5:21 PM
Nov 12, 2026
Filed
Nov 12, 2026
Documents
14
Size
326.6 KB
Summary
Akari Therapeutics Plc: reports Q3 2026 financial results
What happened Akari Therapeutics Plc announced financial results for the 3rd quarter of the year ending Dec 31, 2026 in a press release dated Nov 12, 2026. The company furnished the press release as Exhibit 99.1 to its Current Report on Form 8-K filed Nov 12, 2026.
Key details
- Item 2.02 reported: results of operations and financial condition.
- Press release dated Nov 12, 2026 is furnished as Exhibit 99.1 and is incorporated by reference to the Form 8-K.
- The Form 8-K was filed Nov 12, 2026.
Why it may matter Item 2.02 covers the company’s reported results of operations and financial condition and the related information disclosed in the press release. The filing does not show why the insider traded or why the company acted.